Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Pfizer Inc. PFE

Healthcare  —  Drug Manufacturers General
28.67 0.26 0.92% as of 25 Sep
Market cap
$161.7B
P/E
37.7×
S&P 500 Member Dividend Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Pfizer Inc. (PFE) Return on invested capital

Pfizer Inc.'s return on invested capital over the twelve months to 30 June 2026 was 6.30%, down 0.2 percentage points from fiscal 2025 (6.45%). Over the past ten years it has ranged from 0.54% (fiscal 2023) to 20.5% (fiscal 2022); the current reading is higher than 55% of that period. That is in line with the Drug Manufacturers General industry median of 6.30% and above the Healthcare sector median of 0.00%.

Return on invested capital, annual

Annual

Period Return on invested capital Change (points)
FY2025 6.45% 0.59
FY2024 5.86% 5.32
FY2023 0.54% (19.98)
FY2022 20.5% 6.20
FY2021 14.3% 8.66
FY2020 5.66% 1.70
FY2019 3.96% (0.13)
FY2018 4.09% (4.92)
FY2017 9.01% (0.02)
FY2016 9.03% (0.14)

Against its own ten years

Low 0.54% High 20.5%
Ten-year median 6.45%
Current reading's percentile 55

Return on invested capital against peers

Company Return on invested capital
NVO Novo Nordisk A/S compare 28.7%
BMY Bristol Myers Squibb Company compare 13.7%
NVS Novartis AG compare 13.1%
AMGN Amgen Inc. compare 13.0%
GSK GSK PLC Sponsored ADR compare 12.6%
AZN AstraZeneca PLC compare 11.7%
SNY Sanofi compare 6.58%
PFE Pfizer Inc. 6.30%
GILD Gilead Sciences, Inc. compare −4.48%
Drug Manufacturers General industry median 6.30%
Healthcare sector median 0.00%
Market median 0.00%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on PFE